|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | |
| A61K 39/02 | |||
| A61K 39/04 | |||
| C07K 1/00 | |||
| C07K 14/00 | |||
| C07K 17/00 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2968482 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14769340.2 |
| Europos patento paraiškos padavimo data | 2014-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/026766 |
| Data | 2014-03-13 |
| (87) | Numeris | WO 2014/151982 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361790833 P | 2013-03-15 | US |
| (72) |
ALMASSY, Robert, US
SHOWALTER, Richard E., US
THOMSON, James A., US
SISSON, Wes, US
SHIA, Wei-Jong, US
CHEN, Li-Chang, US
LEE, Yang, US
|
| (73) |
TDW Group,
4F, No.631 Ruiguang Road Neihu District, Taipei, 11492,
TW
|
| (54) | ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |
| ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |